{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:56:54Z","timestamp":1792090614631,"version":"4.4.0"},"reference-count":206,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02187-5","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:15:29Z","timestamp":1776705329000},"page":"2973-3028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Microbiome modulating remedies for chronic diseases: a review of current interventions and future directions"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-3064","authenticated-orcid":false,"given":"Mahendra Pratap","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan Hasmukh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhrath Singh","family":"Padya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varalakshmi","family":"Velagacherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwitiya","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6665-3432","authenticated-orcid":false,"given":"Satyajit","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuhin","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2187_CR1","doi-asserted-by":"publisher","first-page":"e15692","DOI":"10.1016\/j.heliyon.2023.e15692","volume":"9","author":"RM Abdel-Megeed","year":"2023","unstructured":"Abdel-Megeed RM, Kadry MO (2023) Amelioration of autophagy and inflammatory signaling pathways via \u03b1-lipoic acid, burdock and bee pollen versus lipopolysaccharide-induced insulin resistance in murine model. Heliyon 9:e15692. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15692","journal-title":"Heliyon"},{"key":"2187_CR2","doi-asserted-by":"publisher","first-page":"999001","DOI":"10.3389\/fmicb.2022.999001","volume":"13","author":"M Afzaal","year":"2022","unstructured":"Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, Hassoun A, Pateiro M, Lorenzo JM, Rusu AV, Aadil RM (2022) Human gut microbiota in health and disease: Unveiling the relationship. Front Microbiol 13:999001. https:\/\/doi.org\/10.3389\/fmicb.2022.999001","journal-title":"Front Microbiol"},{"key":"2187_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/antibiotics12050868","volume":"12","author":"C Airola","year":"2023","unstructured":"Airola C, Severino A, Porcari S, Fusco W, Mullish BH, Gasbarrini A, Cammarota G, Ponziani FR, Ianiro G (2023) Future modulation of gut microbiota: from eubiotics to FMT, engineered bacteria, and phage therapy. Antibiotics 12:868. https:\/\/doi.org\/10.3390\/antibiotics12050868","journal-title":"Antibiotics"},{"key":"2187_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1267\/ahc.20011","volume":"53","author":"NS Akimbekov","year":"2020","unstructured":"Akimbekov NS, Digel I, Sherelkhan DK, Lutfor AB, Razzaque MS (2020) Vitamin D and the host-gut microbiome: a brief overview. Acta Histochem Cytochem 53:33\u201342. https:\/\/doi.org\/10.1267\/ahc.20011","journal-title":"Acta Histochem Cytochem"},{"key":"2187_CR5","doi-asserted-by":"publisher","first-page":"1510564","DOI":"10.3389\/fnut.2024.1510564","volume":"11","author":"LA Alahmari","year":"2024","unstructured":"Alahmari LA (2024) Dietary fiber influence on overall health, with an emphasis on CVD, diabetes, obesity, colon cancer, and inflammation. Front Nutr 11:1510564. https:\/\/doi.org\/10.3389\/fnut.2024.1510564","journal-title":"Front Nutr"},{"key":"2187_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/applmicrobiol3020023","volume":"3","author":"H Aldirawi","year":"2023","unstructured":"Aldirawi H, Franceskrista G, Morales (2023) Univariate and multivariate statistical analysis of microbiome data: an overview. Appl Microbiol 3:322\u2013338. https:\/\/doi.org\/10.3390\/applmicrobiol3020023","journal-title":"Appl Microbiol"},{"key":"2187_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/advances\/nmz004","volume":"10","author":"C Alexander","year":"2019","unstructured":"Alexander C, Swanson KS, Fahey GC, Keith A, Garleb (2019) Perspective: physiologic importance of short-chain fatty acids from nondigestible carbohydrate fermentation. Adv Nutr 10:576\u2013589. https:\/\/doi.org\/10.1093\/advances\/nmz004","journal-title":"Adv Nutr"},{"issue":"4","key":"2187_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MOG.0000000000000949","volume":"39","author":"T Alhobayb","year":"2023","unstructured":"Alhobayb T, Ciorba MA (2023) Clostridium difficile in inflammatory bowel disease. Curr Opin Gastroenterol 39(4):257\u2013262. https:\/\/doi.org\/10.1097\/MOG.0000000000000949","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"2187_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13040710","volume":"13","author":"AJ Alzahrani","year":"2025","unstructured":"Alzahrani AJ, Basma M, Al-Hebshi ZA, Yahia, Effat A, Al-Judaibi KH, Alsaadi and, Al-Judaibi AA (2025) Impact of microbiota diversity on inflammatory bowel disease, Microbe. 13(4): 710. https:\/\/doi.org\/10.3390\/microorganisms13040710","journal-title":"Microbe"},{"key":"2187_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmet.2018.05.004","volume":"28","author":"P Arner","year":"2018","unstructured":"Arner P, Andersson DP, Backdahl J, Dahlman I, Ryden M (2018) Weight gain and impaired glucose metabolism in women are predicted by inefficient subcutaneous fat cell lipolysis, Cell Metab, 28: 45\u201354. https:\/\/doi.org\/10.1016\/j.cmet.2018.05.004","journal-title":"Cell Metab"},{"key":"2187_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5217\/ir.2023.00085","volume":"22","author":"U Arora","year":"2024","unstructured":"Arora U, Kedia S, Ahuja V (2024) The practice of fecal microbiota transplantation in inflammatory bowel disease. Intest Res 22:44\u201364. https:\/\/doi.org\/10.5217\/ir.2023.0008","journal-title":"Intest Res"},{"key":"2187_CR12","doi-asserted-by":"publisher","first-page":"e22156","DOI":"10.7759\/cureus.22156","volume":"14","author":"A Artemev","year":"2022","unstructured":"Artemev A, Naik S, Pougno A, Honnavar P, Shanbhag NM (2022) The association of microbiome dysbiosis with colorectal cancer. Cureus 14:e22156. https:\/\/doi.org\/10.7759\/cureus.22156","journal-title":"Cureus"},{"key":"2187_CR13","doi-asserted-by":"publisher","first-page":"e34092","DOI":"10.1016\/j.heliyon.2024.e34092","volume":"10","author":"S Ashique","year":"2024","unstructured":"Ashique S, Mohanto S, Ahmed MG, Mishra N, Garg A, Chellappan DK, Omara T, Iqbal S, Ivan Kahwa (2024) Gut-brain axis: a cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon 10:e34092. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34092","journal-title":"Heliyon"},{"issue":"1","key":"2187_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/nu14010191","volume":"14","author":"I van Attaye","year":"2021","unstructured":"Attaye I, van Oppenraaij S, Warmbrunn MV, Nieuwdorp M (2021) The role of the gut microbiota on the beneficial effects of ketogenic diets. Nutr 14(1):191. https:\/\/doi.org\/10.3390\/nu14010191","journal-title":"Nutr"},{"key":"2187_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","volume":"72","author":"D Bagnall Richard","year":"2018","unstructured":"Bagnall Richard D, Ingles J, Dinger Marcel E, Cowley Mark J, Samantha BR, Minoche E, Andr\u00e9 S, Lal C, Turner A, Colley S, Rajagopalan Y, Berman A, Ronan D, Fatkin, Semsarian C (2018) Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 72:419\u2013429. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.078","journal-title":"J Am Coll Cardiol"},{"key":"2187_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/advances\/nmy013","volume":"9","author":"MA Bailey","year":"2018","unstructured":"Bailey MA, Hannah D, Holscher (2018) Microbiome-mediated effects of the mediterranean diet on inflammation. Adv Nutr 9:193\u2013206. https:\/\/doi.org\/10.1093\/advances\/nmy013","journal-title":"Adv Nutr"},{"key":"2187_CR17","doi-asserted-by":"publisher","first-page":"100275","DOI":"10.5493\/wjem.v15.i1.100275","volume":"15","author":"S Balaji","year":"2025","unstructured":"Balaji S, Jeyaraman N, Jeyaraman M, Ramasubramanian S, Muthu S, Santos GS, da Fonseca LF, Lana JF (2025) Impact of curcumin on gut microbiome. World J Exp Med 15:100275. https:\/\/doi.org\/10.5493\/wjem.v15.i1.100275","journal-title":"World J Exp Med"},{"key":"2187_CR18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/microorganisms9040697","volume":"9","author":"V Baldelli","year":"2021","unstructured":"Baldelli V, Scaldaferri F, Putignani L, Del Chierico F (2021) The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms 9:697. https:\/\/doi.org\/10.3390\/microorganisms9040697","journal-title":"Microorganisms"},{"key":"2187_CR19","doi-asserted-by":"publisher","first-page":"1048333","DOI":"10.3389\/fnagi.2022.1048333","volume":"14","author":"N Begum","year":"2022","unstructured":"Begum N, Mandhare A, Tryphena KP, Srivastava S, Shaikh MF, Singh SB, Khatri DK (2022) Epigenetics in depression and gut-brain axis: a molecular crosstalk. Front Aging Neurosci 14:1048333. ttps:\/\/doi.org\/10.3389\/fnagi.2022.1048333","journal-title":"Front Aging Neurosci"},{"issue":"14","key":"2187_CR20","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.3390\/jcm11144119","volume":"11","author":"M Biazzo","year":"2022","unstructured":"Biazzo M, Deidda G (2022) Fecal microbiota transplantation as new therapeutic avenue for human diseases. J Clin Med 11(14):4119. https:\/\/doi.org\/10.3390\/jcm11144119","journal-title":"J Clin Med"},{"key":"2187_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3945\/an.117.016568","volume":"8","author":"JK Bird","year":"2017","unstructured":"Bird JK, Raederstorff D, Weber P, Robert E, Steinert (2017) Cardiovascular and antiobesity effects of resveratrol mediated through the gut microbiota. Adv Nutr 8:839\u2013849. https:\/\/doi.org\/10.3945\/an.117.016568","journal-title":"Adv Nutr"},{"key":"2187_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3945\/an.117.016568","volume":"4","author":"DF Birt","year":"2013","unstructured":"Birt DF, Boylston T, Hendrich S, Jane JL, Hollis J, Li L, McClelland J, Moore S, Phillips GJ, Rowling M, Schalinske K, Scott MP, Whitley EM (2013) Resistant starch: promise for improving human health. Adv Nutr 4:587\u2013601. https:\/\/doi.org\/10.3945\/an.117.016568","journal-title":"Adv Nutr"},{"issue":"4","key":"2187_CR23","first-page":"303","volume":"18","author":"H Bischoff","year":"1995","unstructured":"Bischoff H (1995) The mechanism of alpha-glucosidase inhibition in the management of diabetes. Clin Invest Med 18(4):303\u2013311","journal-title":"Clin Invest Med"},{"key":"2187_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/s-0043-1760718","volume":"36","author":"S Boatman","year":"2023","unstructured":"Boatman S, Kohn J, Jahansouz C (2023) The influence of the microbiome on anastomotic leak. Clin Colon Rectal Surg 36:127\u2013132. https:\/\/doi.org\/10.1055\/s-0043-1760718","journal-title":"Clin Colon Rectal Surg"},{"key":"2187_CR25","doi-asserted-by":"publisher","first-page":"105094","DOI":"10.1016\/j.jff.2022.105094","volume":"93","author":"A Bojarczuk","year":"2022","unstructured":"Bojarczuk A, Sk\u0105pska S, Khaneghah AM, Marsza\u0142ek K (2022) Health benefits of resistant starch: a review of the literature. J Funct Foods 93:105094. ttps:\/\/doi.org\/10.1016\/j.jff.2022.105094","journal-title":"J Funct Foods"},{"issue":"2","key":"2187_CR26","first-page":"692","volume":"15","author":"G Bora","year":"2023","unstructured":"Bora G, Gunna A, Kumar MM, Morya S, Awuchi CG, Menaa F (2023) The gut microbiota and chronic diseases: role of probiotics. J Appl Nat Sci 15(2):692. ttps:\/\/doi.org\/10.31018\/jans.v15i2.4540","journal-title":"J Appl Nat Sci"},{"issue":"2","key":"2187_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/microorganisms10020452","volume":"10","author":"J Breton","year":"2022","unstructured":"Breton J, Galmiche M, D\u00e9chelotte P (2022) Dysbiotic gut bacteria in obesity: an overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics. Microorganisms 10(2):452. https:\/\/doi.org\/10.3390\/microorganisms10020452","journal-title":"Microorganisms"},{"key":"2187_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fmicb.2017.00114","volume":"8","author":"NM Breyner","year":"2017","unstructured":"Breyner NM, Michon C, de Sousa CS, Vilas Boas PB, Chain F, Azevedo VA, Langella P, Chatel JM (2017) Microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-\u03baB pathway. Front Microbiol 8:114. https:\/\/doi.org\/10.3389\/fmicb.2017.00114","journal-title":"Front Microbiol"},{"key":"2187_CR29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2337\/dc18-1256","volume":"42","author":"BA Bruno","year":"2019","unstructured":"Bruno BA, Choi D, Thorpe KE, Yu CH (2019) Relationship among diabetes distress, decisional conflict, quality of life, and patient perception of chronic illness care in a cohort of patients with type 2 diabetes and other comorbidities. Diabetes Care 42:1170\u20131177. https:\/\/doi.org\/10.2337\/dc18-1256","journal-title":"Diabetes Care"},{"key":"2187_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/gut.38.4.568","volume":"38","author":"JD Butzner","year":"1996","unstructured":"Butzner JD, Parmar R, Bell CJ, Dalal V (1996) Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38:568\u2013573. https:\/\/doi.org\/10.1136\/gut.38.4.568","journal-title":"Gut"},{"key":"2187_CR31","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3390\/life14111484","volume":"14","author":"V Chaithanya","year":"2024","unstructured":"Chaithanya V, Kumar J, Vajravelu Leela K, Ram M, Thulukanam J (2024) Impact of multistrain probiotic supplementation on glycemic control in type 2 diabetes mellitus: randomized controlled trial. Life 14:1484. https:\/\/doi.org\/10.3390\/life14111484","journal-title":"Life"},{"key":"2187_CR32","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/nu12041082","volume":"12","author":"RM Chakaroun","year":"2020","unstructured":"Chakaroun RM, Massier L, Kovacs P (2020) Gut microbiome, intestinal permeability, and tissue bacteria in metabolic disease: perpetrators or bystanders? Nutrients 12:1082. https:\/\/doi.org\/10.3390\/nu12041082","journal-title":"Nutrients"},{"key":"2187_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.14218\/ERHM.2024.00046","volume":"10","author":"SK Chakrabarti","year":"2025","unstructured":"Chakrabarti SK, Chattopadhyay D, Aging, Damage DNA (2025) Investigating the microbiome\u2019s stealthy impact: a perspective. Explor Res Hypothesis Med 10:106\u2013121. https:\/\/doi.org\/10.14218\/ERHM.2024.00046","journal-title":"Explor Res Hypothesis Med"},{"issue":"6","key":"2187_CR35","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2017","unstructured":"Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9(6):7204\u20137218. https:\/\/doi.org\/10.18632\/oncotarget.23208","journal-title":"Oncotarget"},{"key":"2187_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.canlet.2019.11.019","volume":"469","author":"D Chen","year":"2020","unstructured":"Chen D, Jin D, Huang S, Wu J, Xu M, Liu T, Dong W, Liu X, Wang S, Zhong W, Liu Y (2020) Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett 469:456\u2013467. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.019","journal-title":"Cancer Lett"},{"key":"2187_CR36","doi-asserted-by":"publisher","first-page":"1069954","DOI":"10.3389\/fcimb.2023.1069954","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Liu B, Ren L, Du H, Fei C, Qian C, Li B, Zhang R, Liu H, Li Z, Ma Z (2023) High-fiber diet ameliorates gut microbiota, serum metabolism and emotional mood in type 2 diabetes patients. Front Cell Infect Microbiol 13:1069954. https:\/\/doi.org\/10.3389\/fcimb.2023.1069954","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2187_CR37","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.12998\/wjcc.v8.i8.1361","volume":"8","author":"FS Cheng","year":"2020","unstructured":"Cheng FS, Pan D, Chang B, Jiang M, Sang LX (2020) Probiotic mixture VSL# 3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases 8(8):1361\u20131384. https:\/\/doi.org\/10.12998\/wjcc.v8.i8.1361","journal-title":"World J Clin Cases"},{"key":"2187_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/nu7010017","volume":"7","author":"MA Conlon","year":"2014","unstructured":"Conlon MA, Bird AR (2014) The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7:17\u201344. https:\/\/doi.org\/10.3390\/nu7010017","journal-title":"Nutrients"},{"key":"2187_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature12480","volume":"500","author":"A Cotillard","year":"2013","unstructured":"Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F, Galleron N, Gougis S (2013) Dietary intervention impact on gut microbial gene richness. Nature 500:585\u2013588. https:\/\/doi.org\/10.1038\/nature12480","journal-title":"Nature"},{"key":"2187_CR40","doi-asserted-by":"publisher","first-page":"104821","DOI":"10.1016\/j.ebiom.2023.104821","volume":"97","author":"L Crudele","year":"2023","unstructured":"Crudele L, Gadaleta RM, Cariello M, Moschetta A (2023) Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. EBioMedicine 97:104821. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104821","journal-title":"EBioMedicine"},{"key":"2187_CR41","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/gmb.2023.6","volume":"4","author":"MC Cruz","year":"2023","unstructured":"Cruz MC, Azinheiro S, Pereira SG (2023) Modulation of gut microbiota by diet and probiotics: potential approaches to prevent gestational diabetes mellitus. Gut Microb 4:e17. https:\/\/doi.org\/10.1017\/gmb.2023.6","journal-title":"Gut Microb"},{"key":"2187_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s13668-022-00429-w","volume":"11","author":"C Cuinat","year":"2022","unstructured":"Cuinat C, Stinson SE, Ward WE, Comelli EM (2022) Maternal intake of probiotics to program offspring health. Curr Nutr Rep 11:537\u2013562. https:\/\/doi.org\/10.1007\/s13668-022-00429-w","journal-title":"Curr Nutr Rep"},{"key":"2187_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin N, Antunes CA, Straussman R, Stein-Thoeringer CK, Elinav E (2021) Microbiome and cancer. Cancer Cell 39:1317\u20131341. https:\/\/doi.org\/10.1016\/j.ccell.2021.08.006","journal-title":"Cancer Cell"},{"key":"2187_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13099-021-00446-0","volume":"13","author":"AL Cunningham","year":"2021","unstructured":"Cunningham AL, Stephens JW, Harris DA (2021) Gut microbiota influence in type 2 diabetes mellitus (T2DM). Gut Pathog 13:50. https:\/\/doi.org\/10.1186\/s13099-021-00446-0","journal-title":"Gut Pathog"},{"key":"2187_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods8030092","volume":"8","author":"D Davani-Davari","year":"2019","unstructured":"Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y (2019) Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 8(3):92. https:\/\/doi.org\/10.3390\/foods8030092","journal-title":"Foods"},{"key":"2187_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559\u2013563. https:\/\/doi.org\/10.1038\/nature12820","journal-title":"Nature"},{"key":"2187_CR47","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","volume":"65","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P (2022) Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 65:1925\u20131966. https:\/\/doi.org\/10.1007\/s00125-022-05787-2","journal-title":"Diabetologia"},{"key":"2187_CR48","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","volume":"22","author":"AK DeGruttola","year":"2016","unstructured":"DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E (2016) Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 22:1137\u20131150. https:\/\/doi.org\/10.1097\/MIB.0000000000000750","journal-title":"Inflamm Bowel Dis"},{"key":"2187_CR49","doi-asserted-by":"publisher","first-page":"840245","DOI":"10.3389\/fimmu.2022.840245","volume":"13","author":"E Dempsey","year":"2022","unstructured":"Dempsey E, Corr SC (2022) Lactobacillus spp. for gastrointestinal health: current and future perspectives. Front Immunol 13:840245. https:\/\/doi.org\/10.3389\/fimmu.2022.840245","journal-title":"Front Immunol"},{"key":"2187_CR50","doi-asserted-by":"publisher","first-page":"112839","DOI":"10.1016\/j.biopha.2022.112839","volume":"149","author":"L Du","year":"2022","unstructured":"Du L, Li Q, Yi H, Kuang T, Tang Y, Fan G (2022) Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus. Biomed pharmacother 149:112839. https:\/\/doi.org\/10.1016\/j.biopha.2022.112839","journal-title":"Biomed pharmacother"},{"key":"2187_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01011-14","volume":"5","author":"A Everard","year":"2014","unstructured":"Everard A, Matamoros S, Geurts L, Delzenne NM, Cani PD (2014) Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db\/db mice. MBio 5:10\u2013128. https:\/\/doi.org\/10.1128\/mbio.01011-14","journal-title":"MBio"},{"key":"2187_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.03.017","author":"J Fan","year":"2025","unstructured":"Fan J, Wu Y, Wang X, Ullah H, Ling Z, Liu P, Wang Y, Feng P, Ji J, Li X (2025) The probiotic enhances donor microbiota stability and improves the efficacy of fecal microbiota transplantation for treating colitis. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2025.03.017","journal-title":"J Adv Res"},{"key":"2187_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.chom.2020.06.008","volume":"28","author":"P Fang","year":"2020","unstructured":"Fang P, Kazmi SA, Jameson KG, Hsiao EY (2020) The microbiome as a modifier of neurodegenerative disease risk. Cell Host Microbe 28:201\u2013222. https:\/\/doi.org\/10.1016\/j.chom.2020.06.008","journal-title":"Cell Host Microbe"},{"key":"2187_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1210\/endrev\/bnae025","volume":"46","author":"H Fang","year":"2025","unstructured":"Fang H, Rodrigues e-Lacerda R, Barra NG, Kukje Zada D, Robin N, Mehra A, Schertzer JD (2025) Postbiotic impact on host metabolism and immunity provides therapeutic potential in metabolic disease. Endocr Rev 46:60\u201379. https:\/\/doi.org\/10.1210\/endrev\/bnae025","journal-title":"Endocr Rev"},{"key":"2187_CR55","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/microorganisms12091755","volume":"12","author":"F Fanizzi","year":"2024","unstructured":"Fanizzi F, D\u2019Amico F, Zanotelli Bombassaro I, Zilli A, Furfaro F, Parigi TL, Cicerone C, Fiorino G, Peyrin-Biroulet L, Danese S, Allocca M (2024) The role of fecal microbiota transplantation in IBD. Microorganisms 12:1755. https:\/\/doi.org\/10.3390\/microorganisms12091755","journal-title":"Microorganisms"},{"key":"2187_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2023","unstructured":"Foster JA, Neufeld KA (2023) Gut\u2013brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305\u2013312. https:\/\/doi.org\/10.1016\/j.tins.2013.01.005","journal-title":"Trends Neurosci"},{"key":"2187_CR57","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ynstr.2017.03.001","volume":"7","author":"JA Foster","year":"2017","unstructured":"Foster JA, Rinaman L, Cryan JF (2017) Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress 7:124\u2013136. https:\/\/doi.org\/10.1016\/j.ynstr.2017.03.001","journal-title":"Neurobiol Stress"},{"key":"2187_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","volume":"82","author":"CD Fuchs","year":"2024","unstructured":"Fuchs CD, Simbrunner B, Baumgartner M, Campbell C, Reiberger T, Trauner M (2024) Bile acid metabolism and signalling in liver disease. J Hepatol 82:134\u2013153. https:\/\/doi.org\/10.1016\/j.jhep.2024.09.032","journal-title":"J Hepatol"},{"key":"2187_CR59","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.chom.2022.09.010","volume":"30","author":"J Fuerte-Stone","year":"2022","unstructured":"Fuerte-Stone J, Mimee M (2022) Host happy hour: Phage cocktail targets IBD-associated microbes. Cell Host Microbe 30:1352\u20131353. https:\/\/doi.org\/10.1016\/j.chom.2022.09.010","journal-title":"Cell Host Microbe"},{"key":"2187_CR60","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G (2023) Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients 15:2211. https:\/\/doi.org\/10.3390\/nu15092211","journal-title":"Nutrients"},{"key":"2187_CR61","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Mart\u00edn C (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21:6275. https:\/\/doi.org\/10.3390\/ijms21176275","journal-title":"Int J Mol Sci"},{"key":"2187_CR62","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/ecco-jcc\/jjw224","volume":"11","author":"M Galtier","year":"2017","unstructured":"Galtier M, Sordi LD, Sivignon A, De Vall\u00e9e A, Maura D, Neut C, Rahmouni O, Wannerberger K, Darfeuille-Michaud A, Desreumaux P, Barnich N (2017) Bacteriophages targeting adherent invasive Escherichia coli strains as a promising new treatment for Crohn\u2019s disease. J Crohns Colitis 11:840\u2013847. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw224","journal-title":"J Crohns Colitis"},{"key":"2187_CR63","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509\u20131517. https:\/\/doi.org\/10.2337\/db08-1637","journal-title":"Diabetes"},{"key":"2187_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/nu16030363","volume":"16","author":"R Geesala","year":"2024","unstructured":"Geesala R, Recharla N, Zhang K, Johnson JC, Golovko G, Khanipov K, Brining DL, Shi XZ (2024) Exclusive enteral nutrition beneficially modulates gut microbiome in a preclinical model of crohn\u2019s-like colitis. Nutrients 16:363. https:\/\/doi.org\/10.3390\/nu16030363","journal-title":"Nutrients"},{"key":"2187_CR65","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41587-023-01759-y","volume":"42","author":"YE Gencay","year":"2024","unstructured":"Gencay YE, Jasinskyt\u0117 D, Robert C, Semsey S, Mart\u00ednez V, Petersen A\u00d8, Brunner K, de Santiago Torio A, Salazar A, Turcu IC, Eriksen MK (2024) Engineered phage with antibacterial CRISPR\u2013Cas selectively reduce E. coli burden in mice. Nat Biotechnol 42:265\u2013274. https:\/\/doi.org\/10.1038\/s41587-023-01759-y","journal-title":"Nat Biotechnol"},{"key":"2187_CR66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41522-020-0127-0","volume":"6","author":"PW Gilijamse","year":"2020","unstructured":"Gilijamse PW, Hartstra AV, Levin E, Wortelboer K, Serlie MJ, Ackermans MT, Herrema H, Nederveen AJ, Imangaliyev S, Aalvink S, Sommer M (2020) Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose\u2013response effects on glucose metabolism in human subjects with metabolic syndrome. npj Biofilms Microbiomes 6:16. https:\/\/doi.org\/10.1038\/s41522-020-0127-0","journal-title":"npj Biofilms Microbiomes"},{"issue":"5","key":"2187_CR67","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1053\/j.gastro.2023.01.017","volume":"164","author":"R Gowen","year":"2023","unstructured":"Gowen R, Gamal A, Di Martino L, McCormick TS, Ghannoum MA (2023) Modulating the microbiome for Crohn\u2019s disease treatment. Gastroenterology 164(5):828\u2013840. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.017","journal-title":"Gastroenterology"},{"key":"2187_CR68","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/apt.17049","volume":"56","author":"EL Gulliver","year":"2022","unstructured":"Gulliver EL, Young RB, Chonwerawong M, D\u2019Adamo GL, Thomason T, Widdop JT, Rutten EL, Rossetto Marcelino V, Bryant RV, Costello SP, O\u2019Brien CL (2022) The future of microbiome-based therapeutics. Aliment Pharmacol Ther 56:192\u2013208. https:\/\/doi.org\/10.1111\/apt.17049","journal-title":"Aliment Pharmacol Ther"},{"key":"2187_CR69","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/cells13231987","volume":"13","author":"MA Hemmati","year":"2024","unstructured":"Hemmati MA, Monemi M, Asli S, Mohammadi S, Foroozanmehr B, Haghmorad D, Oksenych V, Eslami M (2024) Using new technologies to analyze gut microbiota and predict cancer risk. Cells 13:1987. https:\/\/doi.org\/10.3390\/cells13231987","journal-title":"Cells"},{"key":"2187_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.gastro.2020.07.048","volume":"160","author":"MR Henn","year":"2021","unstructured":"Henn MR, O\u2019Brien EJ, Diao L, Feagan BG, Sandborn WJ, Huttenhower C, Wortman JR, McGovern BH, Wang-Weigand S, Lichter DI, Chafee M (2021) A phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis. Gastroenterology 160:115\u2013127. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.048","journal-title":"Gastroenterology"},{"key":"2187_CR71","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/immuno4040026","volume":"4","author":"HF Hetta","year":"2024","unstructured":"Hetta HF, Ramadan YN, Alharbi AA, Alsharef S, Alkindy TT, Alkhamali A, Albalawi AS, El Amin H (2024) Gut microbiome as a target of intervention in inflammatory bowel disease pathogenesis and therapy. Immuno 4:400\u2013425. https:\/\/doi.org\/10.3390\/immuno4040026","journal-title":"Immuno"},{"key":"2187_CR72","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3390\/nu11071613","volume":"11","author":"RD Hills","year":"2019","unstructured":"Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR (2019) Gut microbiome: profound implications for diet and disease. Nutrients 11:1613. https:\/\/doi.org\/10.3390\/nu11071613","journal-title":"Nutrients"},{"key":"2187_CR73","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41385-022-00564-1","volume":"15","author":"TC Hitch","year":"2022","unstructured":"Hitch TC, Hall LJ, Walsh SK, Leventhal GE, Slack E, de Wouters T, Walter J, Clavel T (2022) Microbiome-based interventions to modulate gut ecology and the immune system. Mucosal Immunol 15:1095\u20131113. https:\/\/doi.org\/10.1038\/s41385-022-00564-1","journal-title":"Mucosal Immunol"},{"key":"2187_CR74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mucimm.2024.12.005","volume":"18","author":"C Hoskinson","year":"2024","unstructured":"Hoskinson C, Petersen C, Turvey SE (2024) How the early life microbiome shapes immune programming in childhood asthma and allergies. Mucosal Immunol 18:26\u201335. https:\/\/doi.org\/10.1016\/j.mucimm.2024.12.005","journal-title":"Mucosal Immunol"},{"key":"2187_CR75","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1039\/D3FO00044C","volume":"14","author":"H Hu","year":"2023","unstructured":"Hu H, Luo J, Liu Y, Li H, Jin R, Li S, Wei J, Wei H, Chen T (2023) Improvement effect of a next-generation probiotic L. plantarum-pMG36e-GLP-1 on type 2 diabetes mellitus via the gut\u2013pancreas\u2013liver axis. Food Funct 14:3179\u20133195. https:\/\/doi.org\/10.1039\/D3FO00044C","journal-title":"Food Funct"},{"key":"2187_CR77","doi-asserted-by":"publisher","first-page":"e04370","DOI":"10.1128\/spectrum.04370-22","volume":"11","author":"X Huang","year":"2023","unstructured":"Huang X, Hu J, Zhang H, Li J, Zhu X, Liu Y, Liang Y, Mei Y (2023) Clostridium butyricum and chitooligosaccharides in synbiotic combination ameliorate symptoms in a DSS-induced ulcerative colitis mouse model by modulating gut microbiota and enhancing intestinal barrier function. Microbiol Spectr 11:e04370\u2013e04322. https:\/\/doi.org\/10.1128\/spectrum.04370-22","journal-title":"Microbiol Spectr"},{"key":"2187_CR76","doi-asserted-by":"publisher","first-page":"2440111","DOI":"10.1080\/19490976.2024.2440111","volume":"16","author":"H Huang","year":"2024","unstructured":"Huang H, Wang Q, Yang Y, Zhong W, He F, Li J (2024) The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease. Gut Microbes 16:2440111. https:\/\/doi.org\/10.1080\/19490976.2024.2440111","journal-title":"Gut Microbes"},{"key":"2187_CR78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/antibiotics13020151","volume":"13","author":"G Iaquinto","year":"2024","unstructured":"Iaquinto G, Mazzarella G, Sellitto C, Lucariello A, Melina R, Iaquinto S, De Luca A, Rotondi Aufiero V (2024) Antibiotic therapy for active Crohn\u2019s disease targeting pathogens: an overview and update. Antibiotics 13:151. https:\/\/doi.org\/10.3390\/antibiotics13020151","journal-title":"Antibiotics"},{"key":"2187_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1241259","volume":"14","author":"O Ignatyeva","year":"2024","unstructured":"Ignatyeva O, Tolyneva D, Kovalyov A, Matkava L, Terekhov M, Kashtanova D, Zagainova A, Ivanov M, Yudin V, Makarov V, Keskinov A (2024) Christensenella minuta, a new candidate next-generation probiotic: current evidence and future trajectories. Front microbiol 2024;14:1241259. https:\/\/doi.org\/10.3389\/fmicb.2023.1241259","journal-title":"Front microbiol"},{"key":"2187_CR80","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.3390\/ijms23074027","volume":"23","author":"AD Inchingolo","year":"2022","unstructured":"Inchingolo AD, Malcangi G, Inchingolo AM, Piras F, Settanni V, Garofoli G, Palmieri G, Ceci S, Patano A, De Leonardis N, Di Pede C (2022) Benefits and implications of resveratrol supplementation on microbiota modulations: a systematic review of the literature. Int J Mol Sci 23:4027. https:\/\/doi.org\/10.3390\/ijms23074027","journal-title":"Int J Mol Sci"},{"key":"2187_CR81","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/MCG.0000000000001609","volume":"56","author":"A Jena","year":"2022","unstructured":"Jena A, Dutta U, Shah J, Sharma V, Prasad KK, Shivaprakash RM, Mandavdhare HS, Samanta J, Sharma P, Popli P, Sharma AK (2022) Oral fluconazole therapy in patients with active ulcerative colitis who have detectable candida in the stool: a double-blind randomized placebo-controlled trial. J Clin Gastroenterol 56:705\u2013711. https:\/\/doi.org\/10.1097\/MCG.0000000000001609","journal-title":"J Clin Gastroenterol"},{"key":"2187_CR82","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","volume":"156","author":"C Jernberg","year":"2010","unstructured":"Jernberg C, Lofmark S, Edlund C, Jansson JK (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156:3216\u20133223. https:\/\/doi.org\/10.1099\/mic.0.040618-0","journal-title":"Microbiology"},{"key":"2187_CR83","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000051913","volume":"63","author":"O Kanauchi","year":"2001","unstructured":"Kanauchi O, Iwanaga T, Mitsuyama K (2001) Germinated barley foodstuff feeding a novel neutraceutical therapeutic strategy for ulcerative colitis. Digestion 63:60\u201367. https:\/\/doi.org\/10.1159\/000051913","journal-title":"Digestion"},{"key":"2187_CR84","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","volume":"92","author":"PC Kashyap","year":"2017","unstructured":"Kashyap PC, Chia N, Nelson H, Segal E, Elinav E (2017) Microbiome at the frontier of personalized medicine. Mayo Clin Proc 92:1855\u20131864. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.004","journal-title":"Mayo Clin Proc"},{"key":"2187_CR85","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00108-022-01396-8","volume":"63","author":"J Kempski","year":"2022","unstructured":"Kempski J, Huber S (2022) Das Darmmikrobiom in der Pathogenese und Therapie chronisch-entz\u00fcndlicher Darmerkrankungen. Die Innere Medizin 63:1022\u20131027. https:\/\/doi.org\/10.1007\/s00108-022-01396-8","journal-title":"Die Innere Medizin"},{"key":"2187_CR86","doi-asserted-by":"publisher","first-page":"68","DOI":"10.29252\/ibj.23.1.68","volume":"23","author":"L Khalili","year":"2019","unstructured":"Khalili L, Alipour B, Jafar-Abadi MA, Faraji I, Hassanalilou T, Abbasi MM, Vaghef-Mehrabany E, Sani MA (2019) The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-a levels in patients with type 2 diabetes mellitus: a randomized controlled trial. Iran Biomed J 23:68. https:\/\/doi.org\/10.29252\/.23.1.68","journal-title":"Iran Biomed J"},{"key":"2187_CR87","doi-asserted-by":"publisher","first-page":"113728","DOI":"10.1016\/j.celrep.2024.113728","volume":"43","author":"D Kirk","year":"2024","unstructured":"Kirk D, Costeira R, Visconti A, Mirzaei MK, Deng L, Valdes AM, Menni C (2024) Bacteriophages, gut bacteria, and microbial pathways interplay in cardiometabolic health. Cell Rep 43:113728. https:\/\/doi.org\/10.1016\/j.celrep.2024.113728","journal-title":"Cell Rep"},{"key":"2187_CR88","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/gutjnl-2012-303954","volume":"62","author":"D Knights","year":"2013","unstructured":"Knights D, Lassen KG, Xavier RJ (2013) Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 62:1505\u20131510. https:\/\/doi.org\/10.1136\/gutjnl-2012-303954","journal-title":"Gut"},{"key":"2187_CR90","doi-asserted-by":"publisher","first-page":"e109434","DOI":"10.1371\/journal.pone.0109434","volume":"9","author":"LC Kong","year":"2014","unstructured":"Kong LC, Holmes BA, Cotillard A, Habi-Rachedi F, Brazeilles R, Gougis S, Gausser\u00e8s N, Cani PD, Fellahi S, Bastard JP, Kennedy SP (2014) Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS ONE 9:e109434. https:\/\/doi.org\/10.1371\/journal.pone.0109434","journal-title":"PLoS ONE"},{"key":"2187_CR89","doi-asserted-by":"publisher","first-page":"e02192","DOI":"10.1128\/spectrum.02192-21","volume":"10","author":"G Kong","year":"2022","unstructured":"Kong G, L\u00ea Cao KA, Hannan AJ (2022) Alterations in the gut fungal community in a mouse model of Huntington\u2019s disease. Microbiol Spectr 10:e02192\u2013e02121. https:\/\/doi.org\/10.1128\/spectrum.02192-21","journal-title":"Microbiol Spectr"},{"key":"2187_CR91","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","volume":"26","author":"HL Koo","year":"2010","unstructured":"Koo HL, DuPont HL (2010) Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 26:17\u201325. https:\/\/doi.org\/10.1097\/MOG.0b013e328333dc8d","journal-title":"Curr Opin Gastroenterol"},{"key":"2187_CR92","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/pathogens8020070","volume":"8","author":"W Kr\u00fcger","year":"2019","unstructured":"Kr\u00fcger W, Vielreicher S, Kapitan M, Jacobsen ID, Niemiec MJ (2019) Fungal-bacterial interactions in health and disease. Pathogens 8:70. https:\/\/doi.org\/10.3390\/pathogens8020070","journal-title":"Pathogens"},{"key":"2187_CR93","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee M, Chang EB (2021) Inflammatory bowel diseases (IBD) and the microbiome: searching the crime scene for clues. Gastroenterol 160:524\u2009\u2013\u200937 https:\/\/doi.org\/10.1053\/j.gastro.2020.09.056","journal-title":"Gastroenterol"},{"key":"2187_CR94","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","volume":"157","author":"A Levine","year":"2019","unstructured":"Levine A, Wine E, Assa A, Boneh RS, Shaoul R, Kori M, Cohen S, Peleg S, Shamaly H, On A, Millman P (2019) Crohn\u2019s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterol 157:440\u2013450. https:\/\/doi.org\/10.1053\/j.gastro.2019.04.021","journal-title":"Gastroenterol"},{"key":"2187_CR95","doi-asserted-by":"publisher","first-page":"791614","DOI":"10.3389\/fphar.2021.791614","volume":"12","author":"F Li","year":"2021","unstructured":"Li F, Li Q, Zhang Y, Zhou X, Yi R, Zhao X (2021) Effects of xylooligosaccharides on lipid metabolism, inflammation, and gut microbiota in C57BL\/6J mice fed a high-fat diet. Front pharmacol 12:791614. https:\/\/doi.org\/10.3389\/fphar.2021.791614","journal-title":"Front pharmacol"},{"key":"2187_CR96","doi-asserted-by":"publisher","first-page":"e1010373","DOI":"10.1371\/journal.pcbi.1010373","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Sohn J, Genco RJ, Wactawski-Wende J, Goodison S, Diaz PI, Sun Y (2022) Computational approach to modeling microbiome landscapes associated with chronic human disease progression. PLoS Comput Biol 18:e1010373. https:\/\/doi.org\/10.1371\/journal.pcbi.1010373","journal-title":"PLoS Comput Biol"},{"key":"2187_CR97","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.coviro.2021.10.005","volume":"51","author":"G Liang","year":"2021","unstructured":"Liang G, Cobi\u00e1n-G\u00fcemes AG, Albenberg L, Bushman F (2021) The gut virome in inflammatory bowel diseases. Curr Opin Virol 51:190\u2013198. https:\/\/doi.org\/10.1016\/j.coviro.2021","journal-title":"Curr Opin Virol"},{"key":"2187_CR98","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.conb.2019.09.012","volume":"59","author":"N Liberman","year":"2019","unstructured":"Liberman N, Wang SY, Greer EL (2019) Transgenerational epigenetic inheritance: from phenomena to molecular mechanisms. Curr Opin Neurobiol 59:189\u2013206. https:\/\/doi.org\/10.1016\/j.conb.2019.09.012","journal-title":"Curr Opin Neurobiol"},{"key":"2187_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.aibe.2020.04.001","volume":"5","author":"JW Lim","year":"2020","unstructured":"Lim JW, Park T, Tong YW, Yu Z (2020) The microbiome driving anaerobic digestion and microbial analysis. Adv Bioenergy 5:1\u201361. https:\/\/doi.org\/10.1016\/bs.aibe.2020.04.001","journal-title":"Adv Bioenergy"},{"key":"2187_CR100","doi-asserted-by":"publisher","first-page":"178ra41","DOI":"10.1126\/scitranslmed.3005687","volume":"5","author":"AP Liou","year":"2013","unstructured":"Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM (2013) Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5:178ra41. https:\/\/doi.org\/10.1126\/scitranslmed.3005687","journal-title":"Sci Transl Med"},{"key":"2187_CR101","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.3748\/wjg.v27.i25.3837","volume":"27","author":"BN Liu","year":"2021","unstructured":"Liu BN, Liu XT, Liang ZH, Wang JH (2021) Gut microbiota in obesity. World J Gastroenterol 27:3837. https:\/\/doi.org\/10.3748\/wjg.v27.i25.3837","journal-title":"World J Gastroenterol"},{"key":"2187_CR102","doi-asserted-by":"publisher","first-page":"104527","DOI":"10.1016\/j.ebiom.2023.104527","volume":"90","author":"L Liu","year":"2023","unstructured":"Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P (2023) Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine 90:104527. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104527","journal-title":"EBioMedicine"},{"key":"2187_CR103","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/oby.22700","volume":"28","author":"J Ma","year":"2020","unstructured":"Ma J, Li C, Wang J, Gu J (2020) Genetically engineered escherichia coli nissle 1917 secreting GLP-1 analog exhibits potential antiobesity effect in high\u2010fat diet\u2010induced obesity mice. Obesity 28:315\u2013322. https:\/\/doi.org\/10.1002\/oby.22700","journal-title":"Obesity"},{"key":"2187_CR104","doi-asserted-by":"publisher","first-page":"740636","DOI":"10.3389\/fphar.2021.740636","volume":"12","author":"TU Maioli","year":"2021","unstructured":"Maioli TU, Borras-Nogues E, Torres L, Barbosa SC, Martins VD, Langella P, Azevedo VA, Chatel JM (2021) Possible benefits of Faecalibacterium prausnitzii for obesity-associated gut disorders. Front Pharmacol 12:740636. https:\/\/doi.org\/10.3389\/fphar.2021.740636","journal-title":"Front Pharmacol"},{"key":"2187_CR105","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3390\/cells10113164","volume":"10","author":"IJ Malesza","year":"2021","unstructured":"Malesza IJ, Malesza M, Walkowiak J, Mussin N, Walkowiak D, Aringazina R, Bartkowiak-Wieczorek J, M\u0105dry E (2021) High-fat, western-style diet, systemic inflammation, and gut microbiota: a narrative review. Cells 10:3164. https:\/\/doi.org\/10.3390\/cells10113164","journal-title":"Cells"},{"issue":"4","key":"2187_CR106","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","volume":"12","author":"P Markowiak-Kope\u0107","year":"2020","unstructured":"Markowiak-Kope\u0107 P, \u015ali\u017cewska K (2020) The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients 12(4):1107. https:\/\/doi.org\/10.3390\/nu12041107","journal-title":"Nutrients"},{"key":"2187_CR107","doi-asserted-by":"publisher","first-page":"fuad039","DOI":"10.1093\/femsre\/fuad039","volume":"47","author":"R Mart\u00edn","year":"2023","unstructured":"Mart\u00edn R, Rios-Covian D, Huillet E, Auger S, Khazaal S, Berm\u00fadez-Humar\u00e1n LG, Sokol H, Chatel JM, Langella P (2023) Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev 47:fuad039. https:\/\/doi.org\/10.1093\/femsre\/fuad039","journal-title":"FEMS Microbiol Rev"},{"key":"2187_CR108","doi-asserted-by":"publisher","first-page":"558924","DOI":"10.3389\/fphar.2020.01153","volume":"11","author":"D Maseda","year":"2020","unstructured":"Maseda D, Ricciotti E (2020) NSAID\u2013gut microbiota interactions. Front Pharmacol 11:558924. https:\/\/doi.org\/10.3389\/fphar.2020.01153","journal-title":"Front Pharmacol"},{"key":"2187_CR109","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/nu12040944","volume":"12","author":"MC Mentella","year":"2020","unstructured":"Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GA (2020) Nutrition, IBD and gut microbiota: a review. Nutrients 12:944. https:\/\/doi.org\/10.3390\/nu12040944","journal-title":"Nutrients"},{"key":"2187_CR110","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41598-020-78285-3","volume":"11","author":"DR Michael","year":"2021","unstructured":"Michael DR, Davies TS, Jack AA, Masetti G, Marchesi JR, Wang D, Mullish BH, Plummer SF (2021) Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults. Sci Rep 11:5. https:\/\/doi.org\/10.1038\/s41598-020-78285-3","journal-title":"Sci Rep"},{"key":"2187_CR111","doi-asserted-by":"publisher","first-page":"2186098","DOI":"10.1080\/19490976.2023.2186098","volume":"15","author":"S Mills","year":"2023","unstructured":"Mills S, Yang B, Smith GJ, Stanton C, Ross RP (2023) Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond. Gut Microbes 15:2186098. https:\/\/doi.org\/10.1080\/19490976.2023.2186098","journal-title":"Gut Microbes"},{"key":"2187_CR112","doi-asserted-by":"publisher","first-page":"67","DOI":"10.12938\/bmfh.18-001","volume":"37","author":"J Minami","year":"2018","unstructured":"Minami J, Iwabuchi N, Tanaka M, Yamauchi K, Abe F, Sakane N (2018) Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial. Biosci Microbiota Food Health. 2018;37:67\u201375. https:\/\/doi.org\/10.12938\/bmfh.18-001","journal-title":"Biosci Microbiota Food Health"},{"key":"2187_CR113","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1136\/gutjnl-2022-327365","volume":"72","author":"SP Mishra","year":"2023","unstructured":"Mishra SP, Wang B, Jain S, Ding J, Rejeski J, Furdui CM, Kitzman DW, Taraphder S, Brechot C, Kumar A, Yadav H (2023) A mechanism by which gut microbiota elevates permeability and inflammation in obese\/diabetic mice and human gut. Gut 72:1848\u20131865. https:\/\/doi.org\/10.1136\/gutjnl-2022-327365","journal-title":"Gut"},{"key":"2187_CR114","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13099-024-00635-7","volume":"16","author":"C Mo","year":"2024","unstructured":"Mo C, Lou X, Xue J, Shi Z, Zhao Y, Wang F, Chen G (2024) The influence of Akkermansia muciniphila on intestinal barrier function. Gut Pathog 16:41. https:\/\/doi.org\/10.1186\/s13099-024-00635-7","journal-title":"Gut Pathog"},{"key":"2187_CR115","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/dom.12861","volume":"19","author":"R Mobini","year":"2017","unstructured":"Mobini R, Tremaroli V, St\u00e5hlman M, Karlsson F, Levin M, Ljungberg M, Sohlin M, Bert\u00e9us Forslund H, Perkins R, B\u00e4ckhed F, Jansson PA (2017) Metabolic effects of L actobacillus reuteri DSM 17938 in people with type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab 19:579\u2013589. https:\/\/doi.org\/10.1111\/dom.12861","journal-title":"Diabetes Obes Metab"},{"key":"2187_CR116","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/1567205020666230718160914","volume":"20","author":"MT Moghadam","year":"2023","unstructured":"Moghadam MT, Ram\u00edrez-Coronel AA, Darijani S, Akbarizadeh MR, Naderifar M, Soltaninejad S, Shahbazi S, Dousari AS, Mojtahedi A, Akhavan-Sigari R (2023) Perturbations in microbiota composition as a novel mediator in neuropsychiatric, neurological and mental disorders: preventive and therapeutic complementary therapies to balance the change. Curr Alzheimer Res 20:213\u2013223. https:\/\/doi.org\/10.2174\/1567205020666230718160914","journal-title":"Curr Alzheimer Res"},{"key":"2187_CR117","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/MCO.0000000000000209","volume":"18","author":"EA Murphy","year":"2015","unstructured":"Murphy EA, Velazquez KT, Herbert KM (2015) Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care 18:515\u2013520. https:\/\/doi.org\/10.1097\/MCO.0000000000000209","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2187_CR118","doi-asserted-by":"publisher","first-page":"699","DOI":"10.12688\/f1000research.18992.1","volume":"8","author":"R Nagpal","year":"2019","unstructured":"Nagpal R, Shively CA, Register TC, Craft S, Yadav H (2019) Gut microbiome-Mediterranean diet interactions in improving host health. F1000Res 8:699. https:\/\/doi.org\/10.12688\/f1000research.18992.1","journal-title":"F1000Res"},{"key":"2187_CR119","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4161\/gmic.28572","volume":"5","author":"S Narushima","year":"2014","unstructured":"Narushima S, Sugiura Y, Oshima K, Atarashi K, Hattori M, Suematsu M, Honda K (2014) Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia. Gut Microbes 5:333\u2013339. https:\/\/doi.org\/10.4161\/gmic.28572","journal-title":"Gut Microbes"},{"key":"2187_CR120","doi-asserted-by":"publisher","first-page":"156684","DOI":"10.1155\/2023\/1566684","volume":"2023","author":"MK Niazi","year":"2023","unstructured":"Niazi MK, Hassan F, Tufail T, Ismail MA, Riaz K (2023) The role of microbiome in psychiatric diseases (insomnia and anxiety\/depression) with microbiological mechanisms. Adv Gut Microbiome Res 2023:1566684. https:\/\/doi.org\/10.1155\/2023\/1566684","journal-title":"Adv Gut Microbiome Res"},{"key":"2187_CR121","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2017.05.055","volume":"153","author":"AC Nicolucci","year":"2017","unstructured":"Nicolucci AC, Hume MP, Mart\u00ednez I, Mayengbam S, Walter J, Reimer RA (2017) Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterol 153:711\u2013722. https:\/\/doi.org\/10.1053\/j.gastro.2017.05.055","journal-title":"Gastroenterol"},{"key":"2187_CR122","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1038\/s41467-023-42788-0","volume":"14","author":"L Ning","year":"2023","unstructured":"Ning L, Zhou YL, Sun H, Zhang Y, Shen C, Wang Z, Xuan B, Zhao Y, Ma Y, Yan Y, Tong T (2023) Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat Commun 14:7135. https:\/\/doi.org\/10.1038\/s41467-023-42788-0","journal-title":"Nat Commun"},{"key":"2187_CR123","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4239\/wjd.v15.i5.1001","volume":"15","author":"D Nitzke","year":"2024","unstructured":"Nitzke D, Czermainski J, Rosa C, Coghetto C, Fernandes SA, Carteri RB (2024) Increasing dietary fiber intake for type 2 diabetes mellitus management: a systematic review. World J Diabetes 15:1001. https:\/\/doi.org\/10.4239\/wjd.v15.i5.1001","journal-title":"World J Diabetes"},{"key":"2187_CR124","doi-asserted-by":"publisher","first-page":"1370658","DOI":"10.3389\/fimmu.2024.1370658","volume":"15","author":"H Niu","year":"2024","unstructured":"Niu H, Zhou M, Zogona D, Xing Z, Wu T, Chen R, Cui D, Liang F, Xu X (2024) Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases. Front Immunol 15:1370658. https:\/\/doi.org\/10.3389\/fimmu.2024.1370658","journal-title":"Front Immunol"},{"key":"2187_CR125","doi-asserted-by":"publisher","first-page":"1897212","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C (2021) The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 13:1897212. https:\/\/doi.org\/10.1080\/19490976.2021.1897212","journal-title":"Gut Microbes"},{"key":"2187_CR126","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/vaccines9060584","volume":"9","author":"N Nunez","year":"2021","unstructured":"Nunez N, R\u00e9ot L, Menu E (2021) Neonatal immune system ontogeny: the role of maternal microbiota and associated factors. How might the non-human primate model enlighten the path? Vaccines 9:584. https:\/\/doi.org\/10.3390\/vaccines9060584","journal-title":"Vaccines"},{"key":"2187_CR127","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12944-015-0019-0","volume":"14","author":"A Ogawa","year":"2015","unstructured":"Ogawa A, Kobayashi T, Sakai F, Kadooka Y, Kawasaki Y (2015) Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects. Lipids Health Dis 14:20. https:\/\/doi.org\/10.1186\/s12944-015-0019-0","journal-title":"Lipids Health Dis"},{"key":"2187_CR128","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10620-020-06090-z","volume":"65","author":"A Oka","year":"2020","unstructured":"Oka A, Sartor RB (2020) Microbial-based and microbial-targeted therapies for inflammatory bowel diseases. Dig Dis Sci 65:757\u2013788. https:\/\/doi.org\/10.1007\/s10620-020-06090-z","journal-title":"Dig Dis Sci"},{"key":"2187_CR129","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/msystems.00115-21","volume":"6","author":"A Oliver","year":"2021","unstructured":"Oliver A, Chase AB, Weihe C, Orchanian SB, Riedel SF, Hendrickson CL, Lay M, Sewall JM, Martiny JB, Whiteson K (2021) High-fiber, whole-food dietary intervention alters the human gut microbiome but not fecal short-chain fatty acids. Msystems 6:10\u2013128. https:\/\/doi.org\/10.1128\/msystems.00115-21","journal-title":"Msystems"},{"key":"2187_CR130","doi-asserted-by":"publisher","first-page":"e2202934119","DOI":"10.1073\/pnas.2202934119","volume":"119","author":"LJ Osborn","year":"2022","unstructured":"Osborn LJ, Schultz K, Massey W, DeLucia B, Choucair I, Varadharajan V, Banerjee R, Fung K, Horak AJ III, Orabi D, Nemet I (2022) A gut microbial metabolite of dietary polyphenols reverses obesity-driven hepatic steatosis. Proc Natl Acad Sci U S A 119:e2202934119. https:\/\/doi.org\/10.1073\/pnas.2202934119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2187_CR131","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jnutbio.2018.03.024","volume":"57","author":"R Otton","year":"2018","unstructured":"Otton R, Bolin AP, Ferreira LT, Marinovic MP, Rocha AL, Mori MA (2018) Polyphenol-rich green tea extract improves adipose tissue metabolism by down-regulating miR-335 expression and mitigating insulin resistance and inflammation. J Nutr Biochem 57:170\u2013179. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.03.024","journal-title":"J Nutr Biochem"},{"key":"2187_CR132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/amh70010005","volume":"70","author":"Q Oudat","year":"2025","unstructured":"Oudat Q, Okour A (2025) The role of probiotics in modulating gut microbiota and metabolic health for weight management: a mini review. Acta microbiol hell 70:5. https:\/\/doi.org\/10.3390\/amh70010005","journal-title":"Acta microbiol hell"},{"key":"2187_CR133","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/cancers15030866","volume":"15","author":"H Pandey","year":"2023","unstructured":"Pandey H, Tang DW, Wong SH, Lal D (2023) Gut microbiota in colorectal cancer: biological role and therapeutic opportunities. Cancers 15:866. https:\/\/doi.org\/10.3390\/cancers15030866","journal-title":"Cancers"},{"key":"2187_CR134","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RW, Connor S, Ng W, Paramsothy R, Xuan W (2017) Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389:1218\u20131228. https:\/\/doi.org\/10.1016\/S0140-6736(17)30182-4","journal-title":"Lancet"},{"key":"2187_CR135","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3904\/kjim.2021.458","volume":"37","author":"SK Park","year":"2022","unstructured":"Park SK, Kang SB, Kim S, Kim TO, Cha JM, Im JP, Choi CH, Kim ES, Seo GS, Eun CS, Han DS (2022) Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis. Korean J Intern Med 37:949. https:\/\/doi.org\/10.3904\/kjim.2021.458","journal-title":"Korean J Intern Med"},{"key":"2187_CR136","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3945\/ajcn.2009.27465","volume":"89","author":"JA Parnell","year":"2009","unstructured":"Parnell JA, Reimer RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89:1751\u20131759. https:\/\/doi.org\/10.3945\/ajcn.2009.27465","journal-title":"Am J Clin Nutr"},{"key":"2187_CR137","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1002\/mbo3.1260","volume":"11","author":"DV Patangia","year":"2022","unstructured":"Patangia DV, Anthony Ryan C, Dempsey E, Paul Ross R, Stanton C (2022) Impact of antibiotics on the human microbiome and consequences for host health. Microbiologyopen 11:e1260. https:\/\/doi.org\/10.1002\/mbo3.1260","journal-title":"Microbiologyopen"},{"key":"2187_CR138","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","volume":"68","author":"P Pathak","year":"2018","unstructured":"Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JY (2018) Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor\u20101 signaling to improve metabolism. Hepatology 68:1574\u20131588. https:\/\/doi.org\/10.1002\/hep.29857","journal-title":"Hepatology"},{"key":"2187_CR139","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/nu17060948","volume":"17","author":"P Perrone","year":"2025","unstructured":"Perrone P, D\u2019Angelo S (2025) Gut microbiota modulation through Mediterranean diet foods: implications for human health. Nutrients 17:948. https:\/\/doi.org\/10.3390\/nu17060948","journal-title":"Nutrients"},{"key":"2187_CR140","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/biomedicines8110513","volume":"8","author":"A Qasem","year":"2020","unstructured":"Qasem A, Elkamel E, Naser SA (2020) Anti-MAP triple therapy supports immunomodulatory therapeutic response in Crohn\u2019s disease through downregulation of NF-\u03baB activation in the absence of MAP detection. Biomedicines 8:513. https:\/\/doi.org\/10.3390\/biomedicines8110513","journal-title":"Biomedicines"},{"key":"2187_CR141","doi-asserted-by":"publisher","first-page":"572912","DOI":"10.3389\/fcimb.2020.572912","volume":"10","author":"J Ramirez","year":"2020","unstructured":"Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H (2020) Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol 10:572912. https:\/\/doi.org\/10.3389\/fcimb.2020.572912","journal-title":"Front Cell Infect Microbiol"},{"key":"2187_CR142","doi-asserted-by":"publisher","first-page":"326","DOI":"10.22037\/ghfbb.v15i4.2600","volume":"15","author":"L Rew","year":"2022","unstructured":"Rew L, Harris MD, Goldie J (2022) The ketogenic diet: its impact on human gut microbiota and potential consequent health outcomes: a systematic literature review. Gastroenterol Hepatol Bed Bench 15:326. https:\/\/doi.org\/10.22037\/ghfbb.v15i4.2600","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"2187_CR143","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2020.08.041","volume":"160","author":"E Rinott","year":"2021","unstructured":"Rinott E, Youngster I, Meir AY, Tsaban G, Zelicha H, Kaplan A, Knights D, Tuohy K, Fava F, Scholz MU, Ziv O (2021) Effects of diet-modulated autologous fecal microbiota transplantation on weight regain. Gastroenterology 160:158\u2013173. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.041","journal-title":"Gastroenterology"},{"key":"2187_CR144","doi-asserted-by":"publisher","first-page":"934695","DOI":"10.3389\/fimmu.2022.934695","volume":"13","author":"VF Rodrigues","year":"2022","unstructured":"Rodrigues VF, Elias-Oliveira J, Pereira \u00cdS, Pereira JA, Barbosa SC, Machado MS, Carlos D (2022) Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Front Immunol 13:934695. https:\/\/doi.org\/10.3389\/fimmu.2022.934695","journal-title":"Front Immunol"},{"key":"2187_CR145","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/mp.2016.50","volume":"21","author":"GB Rogers","year":"2016","unstructured":"Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S (2016) From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry 21:738\u2013748. https:\/\/doi.org\/10.1038\/mp.2016.50","journal-title":"Mol Psychiatry"},{"key":"2187_CR146","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tem.2015.07.002","volume":"26","author":"M Rosenbaum","year":"2015","unstructured":"Rosenbaum M, Knight R, Leibel RL (2015) The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 26:493\u2013501. https:\/\/doi.org\/10.1016\/j.tem.2015.07.002","journal-title":"Trends Endocrinol Metab"},{"key":"2187_CR147","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i14.2078","volume":"29","author":"S Roy","year":"2023","unstructured":"Roy S, Dhaneshwar S (2023) Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives. World J Gastroenterol. 29:2078. https:\/\/doi.org\/10.3748\/wjg.v29.i14.2078","journal-title":"World J Gastroenterol"},{"key":"2187_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lwt.2012.05.014","volume":"50","author":"N Saad","year":"2013","unstructured":"Saad N, Delattre C\u00c9, Urdaci MA, Schmitter JM, Bressollier PH (2013) An overview of the last advances in probiotic and prebiotic field. LWT Food Sci Technol 50:1\u201316. https:\/\/doi.org\/10.1016\/j.lwt.2012.05.014","journal-title":"LWT Food Sci Technol"},{"key":"2187_CR149","doi-asserted-by":"publisher","first-page":"205031212412574","DOI":"10.1177\/20503121241257486","volume":"12","author":"Z Sahle","year":"2024","unstructured":"Sahle Z, Engidaye G, Shenkute Gebreyes D, Adenew B, Abebe TA (2024) Fecal microbiota transplantation and next-generation therapies: a review on targeting dysbiosis in metabolic disorders and beyond. SAGE Open Med 12:20503121241257486. https:\/\/doi.org\/10.1177\/20503121241257486","journal-title":"SAGE Open Med"},{"key":"2187_CR150","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13098-020-00603-6","volume":"12","author":"BI Salles","year":"2020","unstructured":"Salles BI, Cioffi D, Ferreira SR (2020) Probiotics supplementation and insulin resistance: a systematic review. Diabetol Metab Syndr 12:98. https:\/\/doi.org\/10.1186\/s13098-020-00603-6","journal-title":"Diabetol Metab Syndr"},{"key":"2187_CR151","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1017\/S0007114513003875","volume":"111","author":"M Sanchez","year":"2014","unstructured":"Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E, Ngom-Bru C, Berger B, Philippe L, Ammon-Zuffrey C, Leone P (2014) Effect of Lactobacillus rhamnosus CGMCC1. 3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 111:1507\u20131519. https:\/\/doi.org\/10.1017\/S0007114513003875","journal-title":"Br J Nutr"},{"key":"2187_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122948","volume":"354","author":"AA Santos","year":"2024","unstructured":"Santos AA, Duarte R, Duarte M, Arella F, Marques V, Roos S, Rodrigues CM (2024) Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD. Life Sci. 2024;354:122948. https:\/\/doi.org\/10.1016\/j.lfs.2024.122948","journal-title":"Life Sci"},{"key":"2187_CR153","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","volume":"17","author":"M Schirmer","year":"2019","unstructured":"Schirmer M, Garner A, Vlamakis H, Xavier RJ (2019) Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol 17:497\u2013511. https:\/\/doi.org\/10.1038\/s41579-019-0213-6","journal-title":"Nat Rev Microbiol"},{"key":"2187_CR154","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-021-00499-1","volume":"19","author":"DA Schupack","year":"2022","unstructured":"Schupack DA, Mars RA, Voelker DH, Abeykoon JP, Kashyap PC (2022) The promise of the gut microbiome as part of individualized treatment strategies. Nat Rev Gastroenterol Hepatol 19:7\u201325. https:\/\/doi.org\/10.1038\/s41575-021-00499-1","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2187_CR155","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","volume":"73","author":"Y Shan","year":"2022","unstructured":"Shan Y, Lee M, Chang EB (2022) The gut microbiome and inflammatory bowel diseases. Annu Rev Med 73:455\u2013468. https:\/\/doi.org\/10.1146\/annurev-med-042320-021020","journal-title":"Annu Rev Med"},{"key":"2187_CR156","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/ph16040504","volume":"16","author":"M Shanmugham","year":"2023","unstructured":"Shanmugham M, Bellanger S, Leo CH (2023) Gut-derived metabolite, trimethylamine-N-oxide (TMAO) in cardio-metabolic diseases: detection, mechanism, and potential therapeutics. Pharmaceuticals 16:504. https:\/\/doi.org\/10.3390\/ph16040504","journal-title":"Pharmaceuticals"},{"key":"2187_CR157","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/foods13172719","volume":"13","author":"X Shen","year":"2024","unstructured":"Shen X, Ma C, Yang Y, Liu X, Wang B, Wang Y, Zhang G, Bian X, Zhang N (2024) The role and mechanism of probiotics supplementation in blood glucose regulation: a review. Foods 13:2719. https:\/\/doi.org\/10.3390\/foods13172719","journal-title":"Foods"},{"key":"2187_CR158","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.clnesp.2024.08.005","volume":"63","author":"V Shukla","year":"2024","unstructured":"Shukla V, Singh S, Verma S, Verma S, Rizvi AA, Abbas M (2024) Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates. Clin Nutr ESPEN 63:813\u2013820. https:\/\/doi.org\/10.1016\/j.clnesp.2024.08.005","journal-title":"Clin Nutr ESPEN"},{"key":"2187_CR159","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3390\/nu15061510","volume":"15","author":"SR Sidhu","year":"2023","unstructured":"Sidhu SR, Kok CW, Kunasegaran T, Ramadas A (2023) Effect of plant-based diets on gut microbiota: a systematic review of interventional studies. Nutrients 15:1510. https:\/\/doi.org\/10.3390\/nu15061510","journal-title":"Nutrients"},{"key":"2187_CR160","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1086\/592072","volume":"47","author":"CD Sifri","year":"2008","unstructured":"Sifri CD (2008) Quorum sensing: bacteria talk sense. Clin Infect Dis 47:1070\u20131076. https:\/\/doi.org\/10.1086\/592072","journal-title":"Clin Infect Dis"},{"key":"2187_CR161","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biomedicines8010008","volume":"8","author":"AK Sikalidis","year":"2020","unstructured":"Sikalidis AK, Maykish A (2020) The gut microbiome and type 2 diabetes mellitus: discussing a complex relationship. Biomedicines 8:8. https:\/\/doi.org\/10.3390\/biomedicines8010008","journal-title":"Biomedicines"},{"key":"2187_CR162","doi-asserted-by":"publisher","first-page":"508738","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 11:508738. https:\/\/doi.org\/10.3389\/fendo.2020.00025","journal-title":"Front Endocrinol"},{"key":"2187_CR163","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/nu5041417","volume":"5","author":"J Slavin","year":"2013","unstructured":"Slavin J (2013) Fiber and prebiotics: mechanisms and health benefits. Nutrients 5:1417\u20131435. https:\/\/doi.org\/10.3390\/nu5041417","journal-title":"Nutrients"},{"key":"2187_CR164","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Berm\u00fadez-Humar\u00e1n LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci 105:16731\u201316736. https:\/\/doi.org\/10.1073\/pnas.0804812105","journal-title":"Proc Natl Acad Sci"},{"key":"2187_CR165","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrmicro2540","volume":"9","author":"A Spor","year":"2011","unstructured":"Spor A, Koren O, Ley R (2011) Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9:279\u2013290. https:\/\/doi.org\/10.1038\/nrmicro2540","journal-title":"Nat Rev Microbiol"},{"key":"2187_CR166","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1365-2036.1996.d01-509.x","volume":"10","author":"AH Steinhart","year":"1996","unstructured":"Steinhart AH, Hiruki T, Brzezinski A, Baker JP (1996) Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther 10:729\u2013736. https:\/\/doi.org\/10.1046\/j.1365-2036.1996.d01-509.x","journal-title":"Aliment Pharmacol Ther"},{"key":"2187_CR167","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ebiom.2016.10.036","volume":"13","author":"LK Stenman","year":"2016","unstructured":"Stenman LK, Lehtinen MJ, Meland N, Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R, L\u00e4hdeaho ML, Linros J, Apter D (2016) Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults\u2014randomized controlled trial. EBioMedicine 13:190\u2013200. https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.036","journal-title":"EBioMedicine"},{"key":"2187_CR168","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13223-016-0173-6","volume":"13","author":"LT Stiemsma","year":"2017","unstructured":"Stiemsma LT, Turvey SE (2017) Asthma and the microbiome: defining the critical window in early life. Allergy Asthma Clin Immunol 13:3. https:\/\/doi.org\/10.1186\/s13223-016-0173-6","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2187_CR169","doi-asserted-by":"publisher","first-page":"1907272","DOI":"10.1080\/19490976.2021.1907272","volume":"13","author":"MK Stoeva","year":"2021","unstructured":"Stoeva MK, Garcia-So J, Justice N, Myers J, Tyagi S, Nemchek M, McMurdie PJ, Kolterman O, Eid J (2021) Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes 13:1907272. https:\/\/doi.org\/10.1080\/19490976.2021.1907272","journal-title":"Gut Microbes"},{"key":"2187_CR170","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.3390\/ijms21207551","volume":"21","author":"K Suganya","year":"2020","unstructured":"Suganya K, Koo BS (2020) Gut\u2013brain axis: role of gut microbiota on neurological disorders and how probiotics\/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int J Mol Sci 21:7551. https:\/\/doi.org\/10.3390\/ijms21207551","journal-title":"Int J Mol Sci"},{"key":"2187_CR171","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/ph18010055","volume":"18","author":"I Szymczak-Pajor","year":"2025","unstructured":"Szymczak-Pajor I, Drzewoski J, Koz\u0142owska M, Krekora J, \u015aliwi\u0144ska A (2025) The gut microbiota-related antihyperglycemic effect of metformin. Pharmaceuticals 18:55. https:\/\/doi.org\/10.3390\/ph18010055","journal-title":"Pharmaceuticals"},{"key":"2187_CR172","doi-asserted-by":"publisher","unstructured":"Tembhre MK, Imran S, Jaiswal K (2023) The modulatory approaches of microbiome therapeutics. In Microbiome Therapeutics 95\u2013126. https:\/\/doi.org\/10.1016\/B978-0-323-99336-4.00013-6","DOI":"10.1016\/B978-0-323-99336-4.00013-6"},{"key":"2187_CR173","doi-asserted-by":"publisher","first-page":"e67010","DOI":"10.7759\/cureus.67010","volume":"16","author":"S Trehan","year":"2024","unstructured":"Trehan S, Singh G, Bector G, Jain P, Mehta T, Goswami K, Chawla A, Jain A, Puri P, Garg N (2024) Gut dysbiosis and cardiovascular health: a comprehensive review of mechanisms and therapeutic potential. Cureus 16:e67010. https:\/\/doi.org\/10.7759\/cureus.67010","journal-title":"Cureus"},{"key":"2187_CR174","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2741\/3603","volume":"15","author":"EB Troy","year":"2010","unstructured":"Troy EB, Kasper DL (2010) Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci 15:25. https:\/\/doi.org\/10.2741\/3603","journal-title":"Front Biosci"},{"key":"2187_CR175","doi-asserted-by":"publisher","first-page":"719072","DOI":"10.3389\/fcell.2021.719072","volume":"9","author":"H Tudela","year":"2021","unstructured":"Tudela H, Claus SP, Saleh M (2021) Next generation microbiome research: identification of keystone species in the metabolic regulation of host-gut microbiota interplay. Front Cell Dev Biol 9:719072. https:\/\/doi.org\/10.3389\/fcell.2021.719072","journal-title":"Front Cell Dev Biol"},{"key":"2187_CR176","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","volume":"70","author":"LK Ursell","year":"2012","unstructured":"Ursell LK, Metcalf JL, Parfrey LW, Knight R (2012) Defining the human microbiome. Nutr Rev 70:S38\u201344. https:\/\/doi.org\/10.1111\/j.1753-4887.2012.00493.x","journal-title":"Nutr Rev"},{"key":"2187_CR177","doi-asserted-by":"publisher","first-page":"e13498","DOI":"10.1111\/obr.13498","volume":"23","author":"T van Deuren","year":"2022","unstructured":"van Deuren T, Blaak EE, Canfora EE (2022) Butyrate to combat obesity and obesity-associated metabolic disorders: current status and future implications for therapeutic use. Obes Rev 23:e13498. https:\/\/doi.org\/10.1111\/obr.13498","journal-title":"Obes Rev"},{"key":"2187_CR178","doi-asserted-by":"publisher","first-page":"10879","DOI":"10.3390\/ijms252010879","volume":"25","author":"I Ventura","year":"2024","unstructured":"Ventura I, Chomon-Garc\u00eda M, Tom\u00e1s-Aguirre F, Palau-Ferr\u00e9 A, Legidos- Garc\u00eda ME, Murillo-Llorente MT, P\u00e9rez-Bermejo M (2024) Therapeutic and immunologic effects of short-chain fatty acids in inflammatory bowel disease: a systematic review. Int J Mol Sci 25:10879. https:\/\/doi.org\/10.3390\/ijms252010879","journal-title":"Int J Mol Sci"},{"key":"2187_CR179","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-019-49833-3","volume":"9","author":"MK Vester-Andersen","year":"2019","unstructured":"Vester-Andersen MK, Mirsepasi-Lauridsen HC, Prosberg MV, Mortensen CO, Tr\u00e4ger C, Skovsen K, Thorkilgaard T, N\u00f8jgaard C, Vind I, Krogfelt KA, S\u00f8rensen N (2019) Increased abundance of proteobacteria in aggressive Crohn\u2019s disease seven years after diagnosis. Sci Rep 9:13473. https:\/\/doi.org\/10.1038\/s41598-019-49833-3","journal-title":"Sci Rep"},{"key":"2187_CR180","doi-asserted-by":"publisher","first-page":"106337","DOI":"10.1016\/j.jff.2024.106337","volume":"119","author":"V Victoria Obayomi","year":"2024","unstructured":"Victoria Obayomi V, Olaniran AF, Owa SO (2024) Unveiling the role of functional foods with emphasis on prebiotics and probiotics in human health: a review. Funct Foods 119:106337. https:\/\/doi.org\/10.1016\/j.jff.2024.106337","journal-title":"Funct Foods"},{"key":"2187_CR181","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/gutjnl-2023-329969","volume":"73","author":"AV Vila","year":"2024","unstructured":"Vila AV, Zhang J, Liu M, Faber KN, Weersma RK (2024) Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases. Gut 73:1909\u20131920. https:\/\/doi.org\/10.1136\/gutjnl-2023-329969","journal-title":"Gut"},{"key":"2187_CR182","doi-asserted-by":"publisher","first-page":"819467","DOI":"10.1155\/2012\/819467","volume":"2012","author":"JC Waite","year":"2012","unstructured":"Waite JC, Skokos D (2012) Th17 response and inflammatory autoimmune diseases. Int J Inflamm 2012:819467. https:\/\/doi.org\/10.1155\/2012\/819467","journal-title":"Int J Inflamm"},{"key":"2187_CR183","doi-asserted-by":"publisher","first-page":"854885","DOI":"10.3389\/fcimb.2022.854885","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang H, Gao Z, Zhang Q, Gu C (2022) The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Front Cell Infect Microbiol 12:854885. https:\/\/doi.org\/10.3389\/fcimb.2022.854885","journal-title":"Front Cell Infect Microbiol"},{"key":"2187_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041202","volume":"15","author":"Q Wang","year":"2023","unstructured":"Wang Q, Guo H, Mao W, Qian X, Liu Y (2023) The oral delivery system of modified GLP-1 by probiotics for T2DM. Pharmaceutics. 15:1202. https:\/\/doi.org\/10.3390\/pharmaceutics15041202","journal-title":"Pharmaceutics"},{"key":"2187_CR185","doi-asserted-by":"publisher","first-page":"117302","DOI":"10.1016\/j.biopha.2024.117302","volume":"179","author":"X Wang","year":"2024","unstructured":"Wang X, Peng J, Cai P, Xia Y, Yi C, Shang A, Akanyibah FA, Mao F (2024) The emerging role of the gut microbiota and its application in inflammatory bowel disease. Biomed Pharmacother 179:117302. https:\/\/doi.org\/10.1016\/j.biopha.2024.117302","journal-title":"Biomed Pharmacother"},{"key":"2187_CR186","doi-asserted-by":"publisher","first-page":"802","DOI":"10.21037\/atm-22-3236","volume":"10","author":"ZJ Wei","year":"2022","unstructured":"Wei ZJ, Dong HB, Ren YT, Jiang B (2022) Efficacy and safety of fecal microbiota transplantation for the induction of remission in active ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Ann Transl Med 10:802. https:\/\/doi.org\/10.21037\/atm-22-3236","journal-title":"Ann Transl Med"},{"key":"2187_CR187","doi-asserted-by":"publisher","first-page":"102402","DOI":"10.1016\/j.arr.2024.102402","volume":"99","author":"Z Weijie","year":"2024","unstructured":"Weijie Z, Meng Z, Chunxiao W, Lingjie M, Anguo Z, Yan Z, Xinran C, Yanjiao X, Li S (2024) Obesity-induced chronic low-grade inflammation in adipose tissue: a pathway to Alzheimer\u2019s disease. Ageing Res Rev 99:102402. https:\/\/doi.org\/10.1016\/j.arr.2024.102402","journal-title":"Ageing Res Rev"},{"key":"2187_CR188","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ebiom.2018.11.046","volume":"39","author":"A Whang","year":"2019","unstructured":"Whang A, Nagpal R, Yadav H (2019) Bi-directional drug-microbiome interactions of anti-diabetics. EBioMedicine 39:591\u2013602. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.046","journal-title":"EBioMedicine"},{"key":"2187_CR189","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pt.2012.02.008","volume":"28","author":"MJ Wolff","year":"2012","unstructured":"Wolff MJ, Broadhurst MJ, Loke PN (2012) Helminthic therapy: improving mucosal barrier function. Trends Parasitol 28:187\u2013194. https:\/\/doi.org\/10.1016\/j.pt.2012.02.008","journal-title":"Trends Parasitol"},{"key":"2187_CR190","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ebiom.2019.05.066","volume":"44","author":"K Wortelboer","year":"2019","unstructured":"Wortelboer K, Nieuwdorp M, Herrema H (2019) Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine 44:716\u201329. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.066","journal-title":"EBioMedicine"},{"key":"2187_CR191","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00253-024-13163-w","volume":"108","author":"YQ Wu","year":"2024","unstructured":"Wu YQ, Zou ZP, Zhou Y, Ye BC (2024) Dual engineered bacteria improve inflammatory bowel disease in mice. Appl Microbiol Biotechnol 108:333. https:\/\/doi.org\/10.1007\/s00253-024-13163-w","journal-title":"Appl Microbiol Biotechnol"},{"key":"2187_CR192","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S2468-1253(21)00299-5","volume":"7","author":"H Yanai","year":"2022","unstructured":"Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, Cohen NA, Ron Y, Goren I, Leibovitzh H, Wardi J (2022) The Crohn\u2019s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn\u2019s disease (CDED-AD): an open-label, pilot, randomised trial. Lancet Gastroenterol Hepatol 7:49\u201359. https:\/\/doi.org\/10.1016\/S2468-1253(21)00299-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2187_CR193","doi-asserted-by":"publisher","first-page":"e00532","DOI":"10.1128\/msystems.00532-24","volume":"9","author":"C Yang","year":"2024","unstructured":"Yang C, Lan R, Zhao L, Pu J, Hu D, Yang J, Zhou H, Han L, Ye L, Jin D, Xu J (2024a) Prevotella copri alleviates hyperglycemia and regulates gut microbiota and metabolic profiles in mice. MSystems 9:e00532\u2013e00524. https:\/\/doi.org\/10.1128\/msystems.00532-24","journal-title":"MSystems"},{"key":"2187_CR194","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1039\/D3FO04681H","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Wang J, Wu W, Su C, Wu Y, Li Q (2024b) Xylooligosaccharides ameliorate insulin resistance by increasing Akkermansia muciniphila and improving intestinal barrier dysfunction in gestational diabetes mellitus mice. Food Funct 15:3122\u20133129. https:\/\/doi.org\/10.1039\/d3fo04681h","journal-title":"Food Funct"},{"key":"2187_CR195","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/gidisord7010007","volume":"7","author":"MO Yaqub","year":"2025","unstructured":"Yaqub MO, Jain A, Joseph CE, Edison LK (2025) Microbiome-driven therapeutics: from gut health to precision medicine. Gastrointest Disord 7:7. https:\/\/doi.org\/10.3390\/gidisord7010007","journal-title":"Gastrointest Disord"},{"key":"2187_CR196","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00253-023-12912-7","volume":"108","author":"J Ye","year":"2024","unstructured":"Ye J, Meng Q, Jin K, Luo Y, Yue T (2024) Phage cocktail alleviated type 2 diabetes by reshaping gut microbiota and decreasing proinflammatory cytokines. Appl Microbiol Biotechnol 108:9. https:\/\/doi.org\/10.1007\/s00253-023-12912-7","journal-title":"Appl Microbiol Biotechnol"},{"key":"2187_CR197","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.3390\/ijms22136932","volume":"22","author":"SJ Yoon","year":"2021","unstructured":"Yoon SJ, Lee CB, Chae SU, Jo SJ, Bae SK (2021) The comprehensive Omics approach from metabolomics to advanced omics for development of immune checkpoint inhibitors: Potential strategies for next generation of cancer immunotherapy. Int J Mol Sci 22:6932. https:\/\/doi.org\/10.3390\/ijms22136932","journal-title":"Int J Mol Sci"},{"key":"2187_CR198","doi-asserted-by":"publisher","first-page":"651503","DOI":"10.1155\/2014\/651503","volume":"2014","author":"JF Zambrano-Zaragoza","year":"2014","unstructured":"Zambrano-Zaragoza JF, Romo-Mart\u00ednez EJ, Dur\u00e1n-Avelar MD, Garc\u00eda- Magallanes N, Vibanco-P\u00e9rez N (2014) Th17 cells in autoimmune and infectious diseases. Int J Inflamm 2014:651503. https:\/\/doi.org\/10.1155\/2014\/651503","journal-title":"Int J Inflamm"},{"key":"2187_CR202","doi-asserted-by":"publisher","first-page":"e71108","DOI":"10.1371\/journal.pone.0071108","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 8:e71108. https:\/\/doi.org\/10.1371\/journal.pone.0071108","journal-title":"PLoS ONE"},{"key":"2187_CR199","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ebiom.2015.07.007","volume":"2","author":"C Zhang","year":"2015","unstructured":"Zhang C, Yin A, Li H, Wang R, Wu G, Shen J, Zhang M, Wang L, Hou Y, Ouyang H, Zhang Y (2015a) Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine 2:968\u2013984. https:\/\/doi.org\/10.1016\/j.ebiom.2015.07.007","journal-title":"EBioMedicine"},{"key":"2187_CR203","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1038\/srep14405","volume":"5","author":"XU Zhang","year":"2015","unstructured":"Zhang XU, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L (2015b) Modulation of gut microbiota by berberine and metformin during the treatment of high- fat diet-induced obesity in rats. Sci Rep 5:14405. https:\/\/doi.org\/10.1038\/srep14405","journal-title":"Sci Rep"},{"key":"2187_CR201","doi-asserted-by":"publisher","DOI":"10.3390\/nu16111698","volume":"16","author":"X Zhang","year":"2024","unstructured":"Zhang X, Jia L, Ma Q, Zhang X, Chen M, Liu F, Zhang T, Jia W, Zhu L, Qi W, Wang N (2024) Astragalus polysaccharide modulates the gut microbiota and metabolites of patients with type 2 diabetes in an in vitro fermentation model. Nutrients 16:1698. https:\/\/doi.org\/10.3390\/nu16111698","journal-title":"Nutrients"},{"key":"2187_CR200","doi-asserted-by":"publisher","first-page":"100416","DOI":"10.1016\/j.advnut.2025.100416","volume":"16","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhou C, Li X, Li H, Han Q, Chen Z, Tang W, Yin J (2025) Interactions between gut microbiota, host circadian rhythms, and metabolic diseases. Adv Nutr 16:100416. https:\/\/doi.org\/10.1016\/j.advnut.2025.100416","journal-title":"Adv Nutr"},{"key":"2187_CR204","doi-asserted-by":"publisher","first-page":"2375555","DOI":"10.1080\/21505594.2024.2375555","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yang H, Wu P, Yang S, Xue W, Xu B, Zhang S, Tang B, Xu D (2024) Akkermansia muciniphila: a promising probiotic against inflammation and metabolic disorders. Virulence 15:2375555. https:\/\/doi.org\/10.1080\/21505594.2024.2375555","journal-title":"Virulence"},{"key":"2187_CR205","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12986-022-00712-1","volume":"19","author":"Y Zhong","year":"2022","unstructured":"Zhong Y, Xiao Y, Gao J, Zheng Z, Zhang Z, Yao L, Li D (2022) Curcumin improves insulin sensitivity in high-fat diet-fed mice through gut microbiota. Nutr Metab 19:76. https:\/\/doi.org\/10.1186\/s12986-022-00712-1","journal-title":"Nutr Metab"},{"key":"2187_CR206","unstructured":"Zuvarox T, Belletieri C (2025) Malabsorption Syndromes. In: StatPearls (StatPearls StatPearls Publishing LLC, Treasure Island (FL))"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02187-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:02:54Z","timestamp":1778860974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":206,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2187"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02187-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}